Recent Company News

• 11:46 AM ET Aug 26, 2026
  

  Transcript Intelligence: Wuxi Biologics (Cayman) Q2 Earnings Guidance

• 11:46 AM ET Aug 26, 2026
  

  Transcript Intelligence: Wuxi Biologics (Cayman) Q2 Earnings Themes

• 11:46 AM ET Aug 26, 2026
  

  Transcript Intelligence: Wuxi Biologics (Cayman) Q2 Earnings Q&A

• 03:45 AM ET Aug 26, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (19 total)

• 11:22 PM ET Aug 25, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (43 total)

• 06:04 AM ET Aug 25, 2026
  

  StreetAccount Metrics Recap - Wuxi Biologics (Cayman) H1 Earnings (HK$52.20, 0.00)

• 05:57 AM ET Aug 25, 2026
  

  Wuxi Biologics (Cayman) reports H1 adjusted net income CNY3.31B, +38% vs year-ago CNY2.39B (HK$52.20, 0.00)

• 03:47 AM ET Aug 25, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (30 total)

• 05:41 AM ET Aug 20, 2026
  

  BioNTech to present new data from lung cancer treatment diversified development program at WCLC 2026 ($113.12, 0.00)

• 03:54 AM ET Aug 20, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (27 total)